Obesity and Therapy-Related Toxicity in Patients Treated for Small-Cell Lung Cancer

Abstract

In this group of 262 patients with SCLC, obesity at the start of treatment was not associated with increased toxicity from treatment or a shortened survival. No support for empiric chemotherapy dose reductions based on ideal body weight was evident from this study.